nach oben

Inflammation

Erschienen in:

01.10.2008

Co-cultures of Human Coronary Smooth Muscle Cells and Dimethyl Sulfoxide-differentiated HL60 Cells Upregulate ProMMP9 Activity and Promote Mobility—Modulation By Reactive Oxygen Species

verfasst von: Yohann Bernard, Chantal Melchior, Eric Tschirhart, Jean-Luc Bueb

Erschienen in: Inflammation | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Vascular cells and leukocytes, involved in the development of atherosclerosis, produce cytokines and/or reactive oxygen species (ROS) and matrix metalloproteinases (MMPs) implicated in cell mobility. We investigated by co-culture experiments the effects of human coronary smooth muscle cells (HCSMC) on MMPs characteristics and mobility of neutrophil-like dimethyl sulfoxide-differentiated HL60 cells (≠HL60). The effects of superoxide dismutase (SOD) and catalase were also analyzed. All the studied MMP2 characteristics remained unchanged. HCSMC stimulated MMP9 protein level, activity and mobility of ≠HL60 cells and expressed and secreted a variety of cytokines implicated in atherosclerosis. SOD and catalase increased MMP9 expression, protein level and activity of ≠HL60, but migration of ≠HL60 cells was only decreased by catalase, demonstrating that ROS are more efficient in modulating MMP9 activity of ≠HL60 than their mobility. Finally, HCSMC being able to stimulate ≠HL60, their co-cultures may represent an in vitro approach to study cellular interactions occurring in vivo during atherosclerosis.

Ross, R. 1999. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340:115–126.PubMedCrossRef

Hansson, G. K. 2001. Regulation of immune mechanisms in atherosclerosis. Ann. N. Y. Acad. Sci. 947:157–165.PubMed

Libby, P. 2002. Inflammation in atherosclerosis. Nature 420:868–874.PubMedCrossRef

Newby, A. C. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85:1–31.PubMedCrossRef

Kai, H., H. Ikeda, H. Yasukawa, M. Kai, Y. Seki, F. Kuwahara, T. Ueno, K. Sugi, and T. Imaizumi. 1998. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 32:368–372.PubMedCrossRef

Ferroni, P., S. Basili, F. Martini, C. M. Cardarello, F. Ceci, M. Di Franco, G. Bertazzoni, P. P. Gazzaniga, and C. Alessandri. 2003. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation. J. Investig. Med. 51:295–300.PubMedCrossRef

Bueb, J.-L., D. Zardini, E. Tschirhart, M. Gloesener, G. Gilson, and D. R. Wagner. 2003. Increased levels of Matrix Metalloproteinase-9 in patients with acute myocardial infarction: no correlation with C-Reactive Protein. J. Am. Coll. Cardiol. S265233.

Robertson, L., L. Grip, L. Mattsson Hulten, J. Hulthe, and O. Wiklund. 2007. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention. J. Intern. Med. 262:659–667.PubMedCrossRef

Mauviel, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53:288–295.PubMedCrossRef

10.

Sato, H., T. Takino, T. Kinoshita, K. Imai, Y. Okada, W. G. Stetler Stevenson, and M. Seiki. 1996. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett. 385:238–240.PubMedCrossRef

11.

Denhardt, D. T., B. Feng, D. R. Edwards, E. T. Cocuzzi, and U. M. Malyankar. 1993. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther. 59:329–341.PubMedCrossRef

12.

Chakrabarti, S., and K. D. Patel. 2005. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J. Leukoc. Biol. 78:279–288.PubMedCrossRef

13.

Rajagopalan, S., X. P. Meng, S. Ramasamy, D. G. Harrison, and Z. S. Galis. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98:2572–2579.PubMedCrossRef

14.

Lee, E., A. J. Grodzinsky, P. Libby, S. K. Clinton, M. W. Lark, and R. T. Lee. 1995. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler. Thromb. Vasc. Biol. 15:2284–2289.PubMed

15.

Vanderlaan, P. A., and C. A. Reardon. 2005. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J. Lipid Res. 46:829–838.PubMedCrossRef

16.

Naruko, T., M. Ueda, K. Haze, A. C. van der Wal, C. M. van der Loos, A. Itoh, R. Komatsu, Y. Ikura, M. Ogami, Y. Shimada, S. Ehara, M. Yoshiyama, K. Takeuchi, J. Yoshikawa, and A. E. Becker. 2002. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106:2894–2900.PubMedCrossRef

17.

Collins, S. J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233–1244.PubMed

18.

Bréchard, S., J.-L. Bueb, and E. J. Tschirhart. 2005. Interleukin-8 primes oxidative burst in neutrophil-like HL-60 through changes in cytosolic calcium. Cell Calcium 37:531–540.PubMedCrossRef

19.

Bréchard, S., A. Brunello, J.-L. Bueb, and E. J. Tschirhart. 2006. Modulation by cADPr of Ca²⁺ mobilization and oxidative response in dimethylsulfoxide- or retinoic acid-differentiated HL-60 cells. Biochim. Biophys. Acta. 1763:129–136.PubMedCrossRef

20.

Valentin, F., J.-L. Bueb, C. Capdeville-Atkinson, and E. Tschirhart. 2001. Rac-1-mediated O₂ ^- secretion requires Ca²⁺ influx in neutrophil-like HL-60 cells. Cell Calcium 29:409–415.PubMedCrossRef

21.

Galis, Z. S., M. Muszynski, G. K. Sukhova, E. Simon-Morrissey, E. N. Unemori, M. W. Lark, E. Amento, and P. Libby. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:181–189.PubMed

22.

Ries, C., H. Kolb, and P. E. Petrides. 1994. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 83:3638–3646.PubMed

23.

Sawa, Y., H. Ichikawa, K. Kagisaki, T. Ohata, and H. Matsuda. 1998. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J. Thorac. Cardiovasc. Surg. 116:511–517.PubMedCrossRef

24.

Ridker, P. M., N. Rifai, M. J. Stampfer, and C. H. Hennekens. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772.PubMed

25.

Schonbeck, U., and P. Libby. 2001. CD40 signaling and plaque instability. Circ. Res. 89:1092–1103.PubMedCrossRef

26.

Dreier, R., S. Wallace, S. Fuchs, P. Bruckner, and S. Grassel. 2001. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J. Cell. Sci. 114:3813–3822.PubMed

27.

Christopherson, K. , and R. Hromas. 2001. Chemokine regulation of normal and pathologic immune responses. Stem Cells 19:388–396.PubMedCrossRef

28.

Miller, L. S., E. M. Pietras, L. H. Uricchio, K. Hirano, S. Rao, H. Lin, R. M. O’Connell, Y. Iwakura, A. L. Cheung, G. Cheng, and R. L. Modlin. 2007. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 179:6933–6942.PubMed

29.

Colditz, I., R. Zwahlen, B. Dewald, and M. Baggiolini. 1989. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am. J. Pathol. 134:755–760.PubMed

30.

Gouwy, M., S. Struyf, J. Catusse, P. Proost, and J. Van Damme. 2004. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J. Leukoc. Biol. 76:185–194.PubMedCrossRef

31.

Siwik, D. A., P. J. Pagano, and W. S. Colucci. 2001. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280:C53–C60.PubMed

32.

Oishi, K., and K. Machida. 1997. Inhibition of neutrophil apoptosis by antioxidants in culture medium. Scand. J. Immunol. 45:21–27.PubMedCrossRef

33.

Ali, M. H., S. A. Schlidt, N. S. Chandel, K. L. Hynes, P. T. Schumacker, and B. L. Gewertz. 1999. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am. J. Physiol. 277:L1057–L1065.PubMed

34.

Hashimoto, S., Y. Gon, K. Matsumoto, I. Takeshita, and T. Horie. 2001. N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br. J. Pharmacol. 132:270–276.PubMedCrossRef

35.

Van Wart, H. E., and H. Birkedal-Hansen. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A. 87:5578–5582.PubMedCrossRef

36.

Nishio, E., and Y. Watanabe. 1997. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br. J. Pharmacol. 121:665–670.PubMedCrossRef

37.

Shim, H., E. Shim, H. Lee, J. Hahn, D. Kang, Y. S. Lee, and D. Jeoung. 2006. CAGE, a novel cancer/testis antigen gene, promotes cell motility by activation ERK and p38 MAPK and downregulating ROS. Mol. Cells 21:367–375.PubMed

38.

Lardot, C., F. Broeckaert, D. Lison, J. P. Buchet, and R. Lauwerys. 1996. Exogenous catalase may potentiate oxidant-mediated lung injury in the female Sprague–Dawley rat. J. Toxicol. Environ. Health 47:509–522.PubMedCrossRef

39.

Simonson, S. G., K. E. Welty-Wolf, Y. C. Huang, D. E. Taylor, S. P. Kantrow, M. S. Carraway, J. D. Crapo, and C. A. Piantadosi. 1997. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J. Appl. Physiol. 83:550–558.PubMed

40.

Raineri, I., E. J. Carlson, R. Gacayan, S. Carra, T. D. Oberley, T. T. Huang, and C. J. Epstein. 2001. Strain-dependent high-level expression of a transgene for manganese superoxide dismutase is associated with growth retardation and decreased fertility. Free Radic. Biol. Med. 31:1018–1030.PubMedCrossRef

41.

Rando, T. A., R. S. Crowley, E. J. Carlson, C. J. Epstein, and P. K. Mohapatra. 1998. Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscular dystrophy. Ann. Neurol. 44:381–386.PubMedCrossRef

42.

Chen, X., H. Liang, H. Van Remmen, J. Vijg, and A. Richardson. 2004. Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch. Biochem. Biophys. 422:197–210.PubMedCrossRef

Titel: Co-cultures of Human Coronary Smooth Muscle Cells and Dimethyl Sulfoxide-differentiated HL60 Cells Upregulate ProMMP9 Activity and Promote Mobility—Modulation By Reactive Oxygen Species
verfasst von: Yohann Bernard
Chantal Melchior
Eric Tschirhart
Jean-Luc Bueb
Publikationsdatum: 01.10.2008
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 5/2008
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-008-9077-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Co-cultures of Human Coronary Smooth Muscle Cells and Dimethyl Sulfoxide-differentiated HL60 Cells Upregulate ProMMP9 Activity and Promote Mobility—Modulation By Reactive Oxygen Species

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2008

Establishment of the Insulin Resistance Induced by Inflammatory Response in 3T3-L1 Preadipocytes Cell Line

Thymic Involution Correlates with Severe Ulcerative Colitis Induced by Oral Administration of Dextran Sulphate Sodium in C57BL/6 Mice but not in BALB/c Mice

Ghrelin and Obestatin Levels in Rheumatoid Arthritis

Lipopolysaccharide-Induced Upregulation of Tumor Necrosis Factor-α (TNF-α) in Rat Spinal Cord

Sequential Expression of TLR4 and its Effects on the Myocardium of Rats with Myocardial Ischemia-Reperfusion Injury

Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin